Portfolio
HBM Healthcare Investments holds and manages a well-balanced portfolio with high value-creation potential.
Overview as at 31 December 2023
Currency allocation of assets
Emphasis on US dollar investments
56
340
US dollar (USD)
60
Renminbi (CNY)
16
Euro (EUR)
12
Indian rupee (INR)
5
Other currencies (CAD, DKK, GBP, HDK, SEK)
4
Swiss franc (CHF)
3
#d997b6
#cc5d3f
#60504c
#49753d
#b7d4d8
#cab415
#423e3d
#3880c0
#ad2d3c
#94743a
Allocation of assets
Mainly invested in private companies or in companies originating
from the private companies portfolio.
62
340
Private companies
36
Public (from private) companies
23
Public companies
23
Funds
9
Cash and cash equivalents
7
Other assets
2
#d997b6
#cc5d3f
#60504c
#49753d
#b7d4d8
#cab415
#423e3d
#3880c0
#ad2d3c
#94743a
Development phase of portfolio companies
Mainly invested in revenue generating companies or in companies with products at an advanced stage of development.
69
90
Profitable
39
Products on the market
23
Preclinical
7
Phase I
8
Phase II
16
Phase III
7
#d997b6
#cc5d3f
#60504c
#49753d
#b7d4d8
#cab415
#423e3d
#3880c0
#ad2d3c
#94743a
Therapeutic area of the lead product of portfolio companies
Broadly diversified areas of activity.
79
350
Others
26
Oncology
19
Synthetic biology
15
Central nervous system
12
Digital Health
9
Orphan diseases
8
Immunology/Inflammation
6
Medical technology / diagnostics
5
#d997b6
#cc5d3f
#60504c
#49753d
#b7d4d8
#cab415
#423e3d
#3880c0
#ad2d3c
#94743a